Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection.
about
Breast cancer incidence in a cohort of U.S. flight attendantsAre Risks From Medical Imaging Still too Small to Be Observed or Nonexistent?Radiation dose measurements in coronary CT angiographyComments on potential health effects of MRI-induced DNA lesions: quality is more important to consider than quantityNeutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical reviewRadRAT: a radiation risk assessment tool for lifetime cancer risk projectionFeasibility of a radiation dose conserving CT protocol for myocardial function assessmentSpace radiation risks for astronauts on multiple International Space Station missions.Microdosimetric analysis confirms similar biological effectiveness of external exposure to gamma-rays and internal exposure to 137Cs, 134Cs, and 131IAssessment of out-of-field absorbed dose and equivalent dose in proton fields.Dosimetry for radiopharmaceutical therapyNon-Targeted Effects Models Predict Significantly Higher Mars Mission Cancer Risk than Targeted Effects ModelsClassification of radiation effects for dose limitation purposes: history, current situation and future prospects.Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.The risk of developing a second cancer after receiving craniospinal proton irradiation.Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer.Divergent modification of low-dose ⁵⁶Fe-particle and proton radiation on skeletal muscleEmerging issues in radiogenic cataracts and cardiovascular diseaseRisk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinomaPredicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiationLung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort.Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plansLifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons.How safe is safe enough? Radiation risk for a human mission to MarsA new approach to reduce uncertainties in space radiation cancer risk predictionsInter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation.Visualization of risk of radiogenic second cancer in the organs and tissues of the human body.Imaging Radiation Doses and Associated Risks and Benefits in Subjects Participating in Breast Cancer Clinical Trials.Nanoparticles for Radiation Therapy Enhancement: the Key ParametersRelative Biological Effectiveness of HZE Particles for Chromosomal Exchanges and Other Surrogate Cancer Risk Endpoints.Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patientsLife years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scaleBiological Effectiveness of Accelerated Protons for Chromosome Exchanges.Establishing the radiation risk from fluoroscopic-assisted arthroscopic surgery of the hip.Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapyA CT method for following patients with both prosthetic replacement and implanted tantalum beads: preliminary analysis with a pelvic model and in seven patientsComparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancerCurrent knowledge on radon risk: implications for practical radiation protection? radon workshop, 1/2 December 2015, Bonn, BMUB (Bundesministerium für Umwelt, Naturschutz, Bau und Reaktorsicherheit; Federal Ministry for the Environment, Nature Conse
P2860
Q23917964-28C06660-12CD-4473-90A6-340FEA6A8B0BQ26775615-B2DE6F9A-53FC-4DBE-8A22-22428FE5664AQ26865676-5CB27748-3569-402A-8E0E-C4F6408981AAQ28068478-75AF66DC-15F8-4747-804A-97A205AB925DQ28068549-68C3A937-E58B-49B7-9497-3F9AD61D6BBDQ28390516-95F3A6C4-612A-4A4E-866E-F3976661B9DCQ30405619-DA021EA0-1E5A-44A7-8A7B-6C525D82CA5BQ31159280-08AB08F4-8D47-46B8-BD1C-35E9E110E4E7Q31165088-D05C356D-2319-4EE4-BF07-ADA428BB60DAQ33579632-1ABB2029-6839-4FE8-BFBF-B5FB4F6AEBB1Q33665116-98BADC51-2FA0-48B0-82A6-839F46C2F32DQ33687771-AB816C71-95F5-4FDB-8346-273E2012AFC0Q33907164-7D560A99-EC14-4DC9-9DF3-95CC0DDA11A5Q34081025-36E260C8-46F9-460F-8F53-63FEFD95B65DQ34086830-A02441FA-C542-48CE-8B82-793AEE3FF5B0Q34086854-4592E8E0-6498-4A55-AC59-0186084DEA1CQ34125355-F7372E98-6B78-4154-BCF8-1200CD62BC19Q34366572-425A069B-0385-47CC-BBAB-92D74A18D2D7Q34402676-EEF7F2D1-A220-45D6-89E1-0C46AA1A5192Q34402785-54CA7B74-12CA-48B5-9831-38E89519FB7DQ34580367-53AFE7D0-8F67-4DDF-938F-DA6815B2853FQ34666728-F645FFA1-38B9-40A5-AA45-A02C3D2AAA4AQ34984131-3AF9798C-E468-470D-83B7-B374F74DE19BQ35022381-525DB471-9A71-440F-8D19-CEEF0D9D8AF0Q35196607-B8B96E23-786F-4F7C-9314-A5B14C35D826Q35237529-5C209789-BC01-4719-B1FC-12F6F5BF7B65Q35576919-F4E1DB5C-4B86-4D19-8797-27AA338A8130Q35820496-83AC9A0A-CC1F-4693-BB02-7173AF1CBDDCQ35824563-6A8BA09C-B079-4C5F-BB5C-BA1E55082461Q35998340-DA61E542-B89F-4C75-AF6C-921432D7C28AQ36038142-BB1D532C-89BF-46C0-AC25-3348790D736DQ36110194-72BE5A68-0F74-4AC0-BFD0-805D9F5C5228Q36175270-DA3A3E76-C49C-446E-A0B9-CC4E122796E8Q36188370-47F4347C-8DD1-4343-8F94-8F23EB6D1567Q36298040-BE3483C5-5FEC-4406-8C3E-404F7DA492F1Q36616467-DB84B3FC-FC87-4569-80E1-423D4B3C2493Q36737527-41369992-4136-4C92-A7CC-C1536EE768F8Q36808805-8C15A99E-C235-4529-831B-7C150627BA30Q36983931-F8CD748F-BF6A-4164-976D-5BC08B55FF14Q37110274-4C7061C6-C2C3-498F-9A31-E90302936A5C
P2860
Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Relative biological effectiven ...... on on Radiological Protection.
@ast
Relative biological effectiven ...... on on Radiological Protection.
@en
type
label
Relative biological effectiven ...... on on Radiological Protection.
@ast
Relative biological effectiven ...... on on Radiological Protection.
@en
prefLabel
Relative biological effectiven ...... on on Radiological Protection.
@ast
Relative biological effectiven ...... on on Radiological Protection.
@en
P2860
P1476
Relative biological effectiven ...... on on Radiological Protection.
@en
P2093
Task Group on Radiation Qualit ...... ion on Radiological Protection
P2860
P356
10.1016/S0146-6453(03)00024-1
P577
2003-01-01T00:00:00Z